TransCode in separation agreement with executive
TransCode Therapeutics entered into a separation and transition services agreement with Thomas A. Fitzgerald, effective Sept. 9, 2026, which includes a $1.25 million severance payment.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day